Literature DB >> 9622753

Changes in sulfation patterns of chondroitin sulfate in equine articular cartilage and synovial fluid in response to aging and osteoarthritis.

M P Brown1, L A West, K A Merritt, A H Plaas.   

Abstract

OBJECTIVES: To determine effects of aging on sulfation of chondroitin sulfate (CS) in articular cartilage and synovial fluid from normal equine middle carpal joints, and to determine whether CS compositional analysis can be used to assess alterations in proteoglycan turnover in degenerative cartilage obtained from horses with carpal osteochondral fractures. SAMPLE POPULATION: Carpal articular cartilage and synovial fluid from 44 cadavers with normal joints and from 16 Thoroughbred racehorses during routine carpal arthroscopic surgery. PROCEDURE: After papain/chondroitinase digestion of cartilage, CS disaccharides (unsulfated disaccharide delta Di0S, and monosulfated disaccharides delta Di4S and delta Di6S) were quantified by capillary zone electrophoresis. The CS was purified from synovial fluid chondroitinase digested, and analyzed. The CS nonreducing terminal residues, N-acetylgalctosamine (galNAc) or glucuronic acid adjacent to a 4-sulfated or 6-sulfated galNAc, were quantified.
RESULTS: In cartilage, the delta Di6S-to-delta Di4S ratio increased with age; in degenerative cartilage, this ratio was not significantly different from the normal value. Percentage of delta Di0S decreased with age and was significantly higher in degenerative than in normal cartilage. The galNAc4S and galNAc4,6S represented > or = 96% of the terminal residues. There was a significant decrease in 6-sulfation of the terminal residues in degenerative cartilage.
CONCLUSIONS: 6-Sulfation of internal and terminal CS residues increased with age. Cartilage degeneration in racehorses was accompanied by deposition of CS chains with altered sulfation patterns, in normal and diseased joints of horses > 2 years old, synovial fluid CS was not indicative of cartilage CS and may represent turnover products of a subpopulation of proteoglycan within the matrix.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622753

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

1.  Optimized extraction of glycosaminoglycans from normal and osteoarthritic cartilage for glycomics profiling.

Authors:  Alicia M Hitchcock; Karen E Yates; Sonya Shortkroff; Catherine E Costello; Joseph Zaia
Journal:  Glycobiology       Date:  2006-09-15       Impact factor: 4.313

2.  Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.

Authors:  J D Sandy; C Verscharen
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

3.  Adult bone marrow stromal cell-based tissue-engineered aggrecan exhibits ultrastructure and nanomechanical properties superior to native cartilage.

Authors:  H-Y Lee; P W Kopesky; A Plaas; J Sandy; J Kisiday; D Frisbie; A J Grodzinsky; C Ortiz
Journal:  Osteoarthritis Cartilage       Date:  2010-08-06       Impact factor: 6.576

4.  Composition-function relationships during IL-1-induced cartilage degradation and recovery.

Authors:  A W Palmer; C G Wilson; E J Baum; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2009-03-03       Impact factor: 6.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.